OraSure Technologies, Inc. (NASDAQ: OSUR) has been awarded a contract for up to $16.6 million in total funding from the U.S. Department of Health and Human Services to advance its rapid Zika tests. The rapid Zika tests utilize OraSure’s OraQuick® technology platform, which is the same proven technology used in the company’s rapid HIV, HCV, Continue Reading…
At BFTP’s annual iXchange on May 17, 2016, speaker Byron Reese presented a keynote on Bold Optimism, in which he addressed how to spot key technologies and identify the macro factors that will drive innovation. Reese shares his perspectives in an eight-part video series. View part one on identifying a transformative technology.